Results 201 to 210 of about 60,444 (298)

Remodeling the Inflammatory Microenvironment: Nanomaterial‐Based Targeted Strategies for Systemic Lupus Erythematosus and Lupus Nephritis

Small Science, Volume 6, Issue 3, March 2026.
Current treatments for severe lupus nephritis are limited by side effects due to poor drug targeting. This review explores how smart nanomaterials—like liposomes and biomimetic carriers—can precisely deliver drugs to overactive immune cells and the kidneys. These nanotherapeutics enhance efficacy, reduce toxicity, and enable combination strategies. The
Cheng Zhou, Jiayi Li, Jian Zhang, Haifeng Wang, Haitao Lu, Shunlai Shang, Wenge Li   +6 more
wiley   +1 more source

Oncology Healthcare Providers' Knowledge, Attitudes, and Practices Regarding Chemotherapy-Induced Myelosuppression in Ovarian Cancer in Haikou, China. [PDF]

J Multidiscip Healthc
Liu X, Tao J.
europepmc   +1 more source

Effect of YH0618 soup on chemotherapy-induced toxicity in patients with cancer who have completed chemotherapy: study protocol for a randomized controlled trial [PDF]

, 2016

core   +1 more source

A Core Outcome Set to Guide Future Research on Caesarean Scar Ectopic Pregnancy: COSCAR Consensus Study

BJOG: An International Journal of Obstetrics &Gynaecology, Volume 133, Issue 4, Page 725-738, March 2026.
ABSTRACT Objective To develop a core outcome set (COS) for research on caesarean scar ectopic pregnancy (CSEP) treatment. Design Consensus development study. Setting International. Population Healthcare professionals, researchers, patient advocates, or individuals with lived experience of CSEP.
Simrit Nijjar, Ilan E. Timor‐Tritsch, Andrea Kaelin Agten, Jin Li, Krystle Y. Chong, Munira Oza, Rosanna Acklom, Francesco D'antonio, Lan N. Vuong, Ben Mol, Cecilia Bottomley, Davor Jurkovic   +11 more
wiley   +1 more source

Retrospective analysis of the clinical efficacy of neoadjuvant chemotherapy albumin paclitaxel combined with carboplatin in the treatment of triple-negative breast cancer. [PDF]

Sci Rep
Zhang H, Sun Y, Zhang Y, Zhang P.
europepmc   +1 more source

Bridging FDA Adverse Event Reporting System (FAERS) and Clinical Practice: Comprehensive Characterization of Immune Checkpoint Inhibitors Toxicities in Geriatric Lung Cancer Patients

Thoracic Cancer, Volume 17, Issue 6, March 2026.
Elderly lung cancer patients face increased risks of severe and fatal AEs during ICIs treatment. Reports concerning males, Asians, and anti‐PD‐1 recipients were associated with higher odds of a fatal outcome. Immune‐mediated pneumonitis is the most frequently reported severe AE, calling for heightened vigilance for these high‐risk subgroups.
Yumeng Tian, Xin Nie, Yue Yuan, Qian Wei, SiQi Zhang, Lin Li   +5 more
wiley   +1 more source

Case Report: Analysis of short-term clinical efficacy of trilaciclib in patients with advanced lung neuroendocrine carcinoma undergoing chemotherapy. [PDF]

Front Oncol
Zeng Y, Lin N.
europepmc   +1 more source

Managing the Complex Intersection Between Substance Use Disorders and Infectious Diseases

JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY, Volume 9, Issue 3, March 2026.
Karissa Chow, Amanda Binkley, Jessica Meisner, Samantha Huo, Matthew Hinton   +4 more
wiley   +1 more source

Targeting MCL‐1 and MAPK overcomes venetoclax resistance in FLT3‐ITD‐positive AML cells harbouring activating PTPN11 (SHP‐2) mutations

British Journal of Haematology, Volume 208, Issue 3, Page 905-915, March 2026.
Summary Venetoclax (VEN)‐based therapies have improved the treatment of acute myeloid leukaemia (AML); however, the emergence of resistance remains a major limitation. Mutations in protein tyrosine phosphatase (PTP) non‐receptor type 11 (PTPN11) and FMS like tyrosine kinase 3 with internal tandem duplication (FLT3‐ITD) are common in resistant patients ...
Maximilian Fleischmann, Ole Hansen, Diana Voigtländer, Julia Bechwar, Lenny‐Joseph Schwietzer, Sanja Bahr, Ulf Schnetzke, Mike Fischer, Florian H. Heidel, Tina M. Schnöder, Jörg P. Müller, Andreas Hochhaus, Sebastian Scholl   +12 more
wiley   +1 more source

Radiomics model based on vertebral calcium-suppressed CT images for predicting chemotherapy-induced myelosuppression in nasopharyngeal carcinoma. [PDF]

Front Oncol
Yang Y, Hou J, Zhang Y, Sun Y, Fu Y, Lu Q, Luo T, Huang Z, Yu X.   +8 more
europepmc   +1 more source